Therapy decisions after diagnosis of prostate cancer in men with negative prostate MRI.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 56, doi. 10.1002/pros.24435
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2023 AND VI 83 AND IP 1
Results: 15
1
2
Prostate cancer aggressiveness and financial toxicity among prostate cancer patients.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 44, doi. 10.1002/pros.24434
- By:
- Publication type:
- Article
3
Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 39, doi. 10.1002/pros.24433
- By:
- Publication type:
- Article
4
Safely omitting bone isotope scans in a cohort of grade group 2 prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 128, doi. 10.1002/pros.24444
- By:
- Publication type:
- Article
5
Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based study.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 119, doi. 10.1002/pros.24443
- By:
- Publication type:
- Article
6
Ultrasound‐based radiomics score for pre‐biopsy prediction of prostate cancer to reduce unnecessary biopsies.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 109, doi. 10.1002/pros.24442
- By:
- Publication type:
- Article
7
Acute urinary retention in men: 21‐year trends in incidence, subsequent benign prostatic hyperplasia‐related treatment and mortality: A Danish population‐based cohort study.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 87, doi. 10.1002/pros.24440
- By:
- Publication type:
- Article
8
Differential impact of PI3K/AKT/mTOR signaling on tumor initiation and progression in animal models of prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 97, doi. 10.1002/pros.24441
- By:
- Publication type:
- Article
9
Efficiency and clinical outcomes of Moses technology for holmium laser enucleation of the prostate: An evidence‐based analysis.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 3, doi. 10.1002/pros.24438
- By:
- Publication type:
- Article
10
Impact of COVID‐19 on the progression of benign prostatic hyperplasia and aggravation of related symptoms: A prospective study.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 82, doi. 10.1002/pros.24439
- By:
- Publication type:
- Article
11
Time to second biochemical recurrence as a prognostic indicator in postprostatectomy patients who undergo salvage radiation therapy: An RTOG 9601 based post hoc analysis.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 64, doi. 10.1002/pros.24436
- By:
- Publication type:
- Article
12
SIRT2 promotes cell proliferation and migration through mediating ERK1/2 activation and lactosylceramide accumulation in prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 71, doi. 10.1002/pros.24437
- By:
- Publication type:
- Article
13
Application of European‐specific polygenic risk scores for predicting prostate cancer risk in different ancestry populations.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 30, doi. 10.1002/pros.24431
- By:
- Publication type:
- Article
14
Issue Information.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 1, doi. 10.1002/pros.24379
- Publication type:
- Article
15
Seleno‐aspirin compound AS‐10 promotes histone acetylation ahead of suppressing androgen receptor transcription, G1 arrest, and apoptosis of prostate cancer cells.
- Published in:
- Prostate, 2023, v. 83, n. 1, p. 16, doi. 10.1002/pros.24430
- By:
- Publication type:
- Article